Identification of the variations in the CPT1B and CHKB genes along with the HLA-DQB1*06:02 allele in Turkish narcolepsy patients and healthy persons

Genetic Testing and Molecular Biomarkers

Volumn 18, Issue 4, 2014, Pages 261-268

  Cingoz, Sultan ^a   Agilkaya, Sinem ^a   Oztura, Ibrahim ^a   Eroglu, Secil ^a   Karadeniz, Derya ^b   Evlice, Ahmet ^a   Altungoz, Oguz ^a   Yilmaz, Hikmet ^c   Baklan, Baris ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQB1 ANTIGEN; CARNITINE PALMITOYLTRANSFERASE; CHKB PROTEIN, HUMAN; CHOLINE KINASE; CPT1B PROTEIN, HUMAN; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN; PRIMER DNA;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ALLELE; ARTICLE; CHKB GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CPT1B GENE; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INDEL MUTATION; MALE; MIDDLE AGED; NARCOLEPSY; PARASOMNIA; REM SLEEP; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC); YOUNG ADULT; AGAR GEL ELECTROPHORESIS; CASE CONTROL STUDY; GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; TURKEY;

ALLELES; BASE SEQUENCE; CARNITINE O-PALMITOYLTRANSFERASE; CASE-CONTROL STUDIES; CHOLINE KINASE; DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; FEMALE; GENETIC VARIATION; HAPLOTYPES; HLA-DQ BETA-CHAINS; HUMANS; MALE; NARCOLEPSY; POLYMERASE CHAIN REACTION; TURKEY;

EID: 84897528774     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0391     Document Type: Article

References (45)

1. Aldrich MS. (1992) Narcolepsy. Neurology 42:34-43.
2. Andlauer O, Moore H 4th, Hong SC, et al. (2012) Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 35:1247-1255F.
3. Eddy SF, Morin P Jr, Storey KB. (2006) Differential expression of selected mitochondrial genes in hibernating little brown bats, Myotis lucifugus. J Exp Zool A Comp Exp Biol 305:620-630.
4. Han F, Lin L, Li J, et al. (2012) TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy. Sleep Med 13:269-272.
5. Hara J, Yanagisawa M, Sakurai T. (2005) Difference in obesity phenotype between orexin-nockout mice and orexin neurondeficient mice with same genetic background and environmental conditions. Neurosci Lett 380:239-242.
6. He L, Kim T, Long Q, Liu J, et al. (2012) Carnitine palmitoyltransferase- 1b deficiency aggravates pressure overloadinduced cardiac hypertrophy caused by lipotoxicity. Circulation 126:1705-1716.
7. Hong SC, Lin L, Jeong JH, et al. (2006) A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Sleep 29:1429-1438.
8. Knudsen S, Jennum PJ, Alving J, et al. (2010) Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Sleep 33:169-176.
9. Kok SW, Overeem S, Visscher TL, et al. (2003) Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res 11:1147-1154.
10. Langdon N, Welsh KI, van Dam M, et al. (1984) Genetic markers in narcolepsy. Lancet 2:1178-1180.
11. Lin L, Hungs M, Mignot E. (2001) Narcolepsy and the HLA region. J Neuroimmunol 117:9-20.
12. Lin L, Jin L, Kimura A, et al. (1997) DQ microsatellite association studies in three ethnic groups. Tissue Antigens 50:507-520.
13. Longo N, Amat di San Filippo C, Pasquali M. (2006) Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 142C:77-85.
14. Matsuki K, Grumet FC, Lin X, et al. (1992) DQ rather than DR gene marks susceptibility to narcolepsy. Lancet 339:1052.
15. McGarry JD, Brown NF. (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1-14.
16. Mignot E, Chen W, Black J. (2003) On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy. Sleep 26:646-649.
17. Mignot E, Hayduk R, Black J, et al. (1997) HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20:1012-1020.
18. Mignot E, Lin X, Arrigoni J, et al. (1994) DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 17: S60-67.
19. Mignot E, Lin L, Finn L, et al. (2006) Correlates of sleep onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 129:1609-1623.
20. Mignot E, Lin L, Rogers W, et al. (2001) Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68:686-699.
21. Mignot E, Young T, Lin L, et al. (1999). Nocturnal sleep and daytime sleepiness in normal subjects with HLADQB1* 0602. Sleep 22:347-352.
22. Mignot E, Young T, Lin L, et al. (1998). Reduction of REM sleep latency associated with HLA-DQB1*0602 in normal adults. Lancet 351:727.
23. Miyagawa T, Hohjoh H, Honda Y, et al. (2000) Identification of a telomeric boundary of the HLA region with potential for predisposition to human narcolepsy. Immunogenetics 52:12-18.
24. Miyagawa T, Honda M, Kawashima M, et al. (2009) Polymorphism located between CPT1B and CHKB, and HLADRB1* 1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia). PLoS One 4:e5394.
25. Miyagawa T, Kawashima M, Nishida N, et al. (2008) Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 40:1324-1328.
26. Miyagawa T, Miyadera H, Tanaka S, et al. (2011) Abnormally low serum acylcarnitine levels in narcolepsy patients. Sleep 34: 349-353A.
27. Mochizuki T, Klerman EB, Sakurai T, et al. (2006) Elevated body temperature during sleep in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 291:R533-540.
28. Morris DR, Geballe AP. (2000) Upstream open reading frames as regulators of mRNA translation. Mol Cell Biol 20:8635-8642.
29. Nishino S, Fujiki N, Ripley B, et al. (2001) Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett 313:125-128.
30. Nishino S, Ripley B, Overeem S, et al. (2000). Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39-40.
31. Okun ML, Lin L, Pelin Z, et al. (2002) Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep 25:27-35.
32. Overeem S, Mignot E, van Dijk JG, et al. (2001) Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 18:78-105.
33. Pelin Z, Bozluolcay M, Kaynak D, et al. (2002) Childhood onset of narcolepsy-cataplexy syndrome in Turkey: clinical and genetic study. Turk J Pediatr 44:321-325.
34. Platt B, Riedel G (2011) The cholinergic system, EEG and sleep. Behav Brain Res 221:499-504.
35. Plazzi G, Moghadam KK, Maggi LS, et al. (2011) Autonomic disturbances in narcolepsy. Sleep Med Rev 15:187-196.
36. Sellayah D, Bharaj P, Sikder D (2011) Orexin is required for brown adipose tissue development, differentiation, and function. Cell Metab 14:478-490.
37. Springer MS, Teeling EC, Madsen O, et al. (2001) Integrated fossil and molecular data reconstruct bat echolocation. Proc Natl Acad Sci USA 98:6241-6246.
38. Tafti M, Petit B, Chollet D, et al. (2003) Deficiency in shortchain fatty acid beta-oxidation affects theta oscillations during sleep. Nat Genet 34:320-325.
39. Teeling EC, Scall M, Kao DJ, et al. (2000) Molecular evidence regarding the origin of echolocation and flight in bats. Nature 403:188-192.
40. Teeling EC, Springer MS, Madsen O, et al. (2005) A molecular phylogeny for bats illuminates biogeography and the fossil record. Science 307:580-584.
41. The European Bioinformatics Institute (EMBL-EBI), Multiple Sequence Alignment by ClustelW2, Available at http://www.eb.ac.uk/Tools/msa/clustalw2/ (accessed March 5, 2013).
42. University of California Santa Cruz (UCSC) Human Genome Browser build Feb. 2009 GRCh37/hg19. Available at http://genome.ucsc.edu/(accessed March 5, 2013).
43. Watson NF, Ton TG, Koepsell TD, et al. (2010) Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status? Sleep 33:29-35.
44. WooHI, Joo EY, Hong SB, et al. (2012)Use of PCRwith sequencespecific primers for high-resolution human leukocyte antigen typing of patients with narcolepsy. Ann Lab Med 32:57-65.
45. Yoshida G, Li MX, Horiuchi M, et al. (2006) Fasting-induced reduction in locomotor activity and reduced response of orexin neurons in carnitine-deficient mice. Neurosci Res 55:78-86.